These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27420379)

  • 41. An effective preselection criterion for MODY with an increasingly positive genetic testing rate by NGS: results from two cohorts of Chinese children.
    Cao B; Liu M; Zhang Y; Chen J; Li X; Su C; Yang W; Liu M; Wu D; Li W; Liang X; Wang Q; Wei H; Gong C
    Am J Physiol Endocrinol Metab; 2022 Dec; 323(6):E529-E534. PubMed ID: 36383636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A family with the Arg103Pro mutation in the NEUROD1 gene detected by next-generation sequencing - Clinical characteristics of mutation carriers.
    Szopa M; Ludwig-Galezowska AH; Radkowski P; Skupien J; Machlowska J; Klupa T; Wolkow P; Borowiec M; Mlynarski W; Malecki MT
    Eur J Med Genet; 2016 Feb; 59(2):75-9. PubMed ID: 26773576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism.
    Bennett JT; Vasta V; Zhang M; Narayanan J; Gerrits P; Hahn SH
    Mol Genet Metab; 2015 Mar; 114(3):451-8. PubMed ID: 25555642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted gene panel analysis of Japanese patients with maturity-onset diabetes of the young-like diabetes mellitus: Roles of inactivating variants in the ABCC8 and insulin resistance genes.
    Yorifuji T; Watanabe Y; Kitayama K; Yamada Y; Higuchi S; Mori J; Kato M; Takahashi T; Okuda T; Aoyama T
    J Diabetes Investig; 2023 Mar; 14(3):387-403. PubMed ID: 36504295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
    Harsunen M; Kettunen JLT; Härkönen T; Dwivedi O; Lehtovirta M; Vähäsalo P; Veijola R; Ilonen J; Miettinen PJ; Knip M; Tuomi T
    Diabetologia; 2023 Mar; 66(3):438-449. PubMed ID: 36418577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes.
    Bouldjennet F; Gjesing AP; Azzouz M; Abderrahman SA; El Guecier A; Ali S; Oudjit B; Mennadi-Lacete F; Yargui L; Boudiba A; Chibane A; Touil-Boukoffa C; Hansen T; Raache R
    Diabetes Metab Syndr Obes; 2020; 13():4829-4837. PubMed ID: 33324081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes.
    Zmysłowska A; Jakiel P; Gadzalska K; Majos A; Płoszaj T; Ben-Skowronek I; Deja G; Glowinska-Olszewska B; Jarosz-Chobot P; Klonowska B; Kowalska I; Mlynarski W; Mysliwiec M; Nazim J; Noczynska A; Robak-Kontna K; Skala-Zamorowska E; Skowronska B; Szadkowska A; Szypowska A; Walczak M; Borowiec M
    Diabetes Res Clin Pract; 2022 Jan; 183():109154. PubMed ID: 34826540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic Genetic Testing for Monogenic Diabetes and Congenital Hyperinsulinemia.
    Houghton JAL
    Methods Mol Biol; 2020; 2076():129-177. PubMed ID: 31586326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
    Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohort.
    Billings LK; Shi Z; Resurreccion WK; Wang CH; Wei J; Pollin TI; Udler MS; Xu J
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e372. PubMed ID: 36208030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asian MODY: are we missing an important diagnosis?
    Porter JR; Rangasami JJ; Ellard S; Gloyn AL; Shields BM; Edwards J; Anderson JM; Shaw NJ; Hattersley AT; Frayling TM; Plunkett M; Barrett TG
    Diabet Med; 2006 Nov; 23(11):1257-60. PubMed ID: 17054605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monogenic diabetes in a Chinese population with young-onset diabetes: A 17-year prospective follow-up study in Hong Kong.
    Tsoi STF; Lim C; Ma RCW; Lau ESH; Fan B; Chow E; Kong APS; Chan JCN; Luk AOY
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3823. PubMed ID: 38821874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and genetic analysis in a Chinese cohort of children and adolescents with diabetes/persistent hyperglycemia.
    Ding Y; Li N; Lou D; Zhang Q; Chang G; Li J; Li X; Li Q; Huang X; Wang J; Jiang F; Wang X
    J Diabetes Investig; 2021 Jan; 12(1):48-62. PubMed ID: 32531870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.
    Johansson BB; Irgens HU; Molnes J; Sztromwasser P; Aukrust I; Juliusson PB; Søvik O; Levy S; Skrivarhaug T; Joner G; Molven A; Johansson S; Njølstad PR
    Diabetologia; 2017 Apr; 60(4):625-635. PubMed ID: 27913849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tunisian Maturity-Onset Diabetes of the Young: A Short Review and a New Molecular and Clinical Investigation.
    Moalla M; Safi W; Babiker Mansour M; Hadj Kacem M; Mahfood M; Abid M; Kammoun T; Hachicha M; Mnif-Feki M; Hadj Kacem F; Hadj Kacem H
    Front Endocrinol (Lausanne); 2021; 12():684018. PubMed ID: 34393998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing.
    Ellard S; Lango Allen H; De Franco E; Flanagan SE; Hysenaj G; Colclough K; Houghton JA; Shepherd M; Hattersley AT; Weedon MN; Caswell R
    Diabetologia; 2013 Sep; 56(9):1958-63. PubMed ID: 23771172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Copy Number Variation in GCK in Patients With Maturity-Onset Diabetes of the Young.
    Berberich AJ; Huot C; Cao H; McIntyre AD; Robinson JF; Wang J; Hegele RA
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3428-3436. PubMed ID: 30912798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families.
    Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG
    Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.
    Stanik J; Dusatkova P; Cinek O; Valentinova L; Huckova M; Skopkova M; Dusatkova L; Stanikova D; Pura M; Klimes I; Lebl J; Gasperikova D; Pruhova S
    Diabetologia; 2014 Mar; 57(3):480-4. PubMed ID: 24323243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.